| SEQ_NO | 5 | Date of announcement | 2025/05/23 | Time of announcement | 15:43:39 |
| Subject | Major Subsidiary PMC Announces Lifting of Non-Compete Restrictions on Directors at 2025 Annual Shareholders' Meeting. | ||||
| Date of events | 2025/05/23 | To which item it meets | paragraph 21 | ||
| Statement | 1.Date of the shareholders’ meeting resolution:2025/05/23 2.Name and title of the managerial officer with permission to engage in competitive conduct: Medeon Biodesign, Inc. Legal Representative of Medeon Biodesign, Inc. Yue Teh Jang; Chairman Legal Representative of Medeon Biodesign, Inc. Albert Weng; Director Legal Representative of Medeon Biodesign, Inc. Jenny Chen; Director 3.Items of competitive conduct in which the officer is permitted to engage: Invest in or manage other companies with the same or similar scope of business as PMC 4.Period of permission to engage in the competitive conduct: During the period of serving as director of PMC 5.Circumstances of the resolution (please describe the results of voting in accordance with Article 209 of the Company Act): The proposal was resolved as proposed after the chairman inquired of all attending shareholders. 6.If the permitted competitive conduct belongs to the operator of a mainland China enterprise, the name and title of the directors (if it is not the operator of a mainland China enterprise, please enter ‘N/A’ below):N/A 7.Company name of the mainland China enterprise and the officer’s position in the enterprise:N/A 8.Address of the mainland China enterprise:N/A 9.Operations of the mainland China enterprise:N/A 10.Impact on the company’s finance and business:N/A 11.If the directors have invested in the mainland China enterprise, the monetary amount of the investment and their shareholding ratio:N/A 12.Any other matters that need to be specified:None |
||||